| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |